EPCAM and neoplasm: Since EMT CTCs have also been correlated with disease progression and chemotherapy resistance [10,180]; enrichment systems that allow simultaneous investigation of both EpCAM+ and EpCAM− CTCs are being employed in order to obtain more complete information about the role of EpCAM in tumor progression [181].